APA (7th ed.) Citation

Yalçın, N., Aktaş, S., Uyar, S., & Koca, N. (2026). Correction: Yalçın et al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722. Life (2075-1729), 16(6), 1021. https://doi.org/10.3390/life16061021

Chicago Style (17th ed.) Citation

Yalçın, Nazif, Selman Aktaş, Seyit Uyar, and Nizameddin Koca. "Correction: Yalçın Et Al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722." Life (2075-1729) 16, no. 6 (2026): 1021. https://doi.org/10.3390/life16061021.

MLA (9th ed.) Citation

Yalçın, Nazif, et al. "Correction: Yalçın Et Al. Impact of SGLT2 Inhibitors on Cardiovascular Risk Scores, Metabolic Parameters, and Laboratory Profiles in Type 2 Diabetes. Life 2025, 15 , 722." Life (2075-1729), vol. 16, no. 6, 2026, p. 1021, https://doi.org/10.3390/life16061021.